MTOR and autoimmune polyendocrinopathy: Furthermore, since uniformly strong mTOR expression was observed in all APS-associated ulcer samples, it is unlikely that disease severity—at least in the case of clinically established ulcers—would have an effect on the magnitude of mTOR expression.